Sobi is seeking strategic, culture-enabling and collaborative leader to serve as the Executive Director, National Field Director within the Immunology Franchise, leading the U.S. field organization for two uncontrolled, severe gout therapies—one potentially launching in 2026 (pending FDA approval) and another in 2028 (pending NDA submission and FDA approval). This leader will set the vision, culture, and direction for a team of Area Business Directors, Regional Business Directors, Clinical Account Managers, Strategic Account Directors, and Infusion Education support roles across the United States. Reporting to the Head of U.S. Immunology and Global Gout Franchise, this role will be pivotal in shaping and executing the commercial field strategy for both launches, ensuring sustained success across the gout portfolio, and realization of each asset’s performance goals. This role is flexible on location. Travel to the Waltham, MA office is expected, in addition to field related travel. Total travel time up to 60%.  Essential Responsibilities/Scope of the Job: Including, but not limited to, the following: Strategic leadership Define each brand’s ambition, overarching strategy, and go-to-market plan with other gout leadership — ensuring alignment, synergy, and performance across both assets Achieve or exceed performance goals across both gout assets Oversee budgets and resource allocation across all field activities Actively contribute to the broader Immunology Leadership team Team building and leadership Attract, build, develop, and lead a high-performing, multi-functional field team capable of managing a complex, multi-product rare disease portfolio across the U.S. Deliver a high-impact colleague experience through consistent onboarding, tailored launch training, and early cross-functional connection Drive a culture of Rare Strength: Partnership, Agility, Accountability and Impact Ensure a culture where actions align with Sobi’s compliance expectations Lead continuous improvement in sales force effectiveness and account management capabilities Cross-Functional Collaboration Partner with cross-functional teams (e.g., medical affairs, marketing, market access, patient services, commercial operations) to ensure high impact execution  Foster an integrated ‘ecosystem’ approach across commercial, medical, and market access field teams to ensure seamless customer experiences Drive excellence in customer experience (seamless, human, dependable) across prescribers, infusion centers, and patient support touchpoints Strategic Market Engagement Represent Sobi externally as a trusted leader in gout and rare disease management Build strong relationships with Key Opinion Leaders (KOLs) and accounts (practice, IDN, infusion clinics, strategic accounts) Monitor stakeholder sentiment, market trends, business performance, and competitor activity to inform operational adjustments and strategic decisions 
